Last reviewed · How we verify

adapalene lotion 0.1%

Galderma R&D · Phase 3 active Small molecule

Adapalene is a topical retinoid that works by binding to retinoic acid receptors, modulating gene expression and promoting cell turnover.

Adapalene is a topical retinoid that works by binding to retinoic acid receptors, modulating gene expression and promoting cell turnover. Used for Acne vulgaris, Aging skin.

At a glance

Generic nameadapalene lotion 0.1%
Also known asDifferin Lotion 0.1%, Differin® Lotion 0.1%
SponsorGalderma R&D
Drug classRetinoid
TargetRetinoic acid receptor
ModalitySmall molecule
Therapeutic areaDermatology
PhasePhase 3

Mechanism of action

This leads to increased cell turnover, reduced comedogenesis, and improved skin appearance. Adapalene's mechanism is similar to other retinoids, but its unique formulation allows for better penetration and reduced irritation.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: